BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koh JJK, Cheng RX, Yap Y, Haldane V, Tan YG, Teo KWQ, Srivastava A, Ong PS, Perel P, Legido-Quigley H. Access and adherence to medications for the primary and secondary prevention of atherosclerotic cardiovascular disease in Singapore: a qualitative study. Patient Prefer Adherence 2018;12:2481-98. [PMID: 30538432 DOI: 10.2147/PPA.S176256] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Castillo-laborde C, Hirmas-adauy M, Matute I, Jasmen A, Urrejola O, Molina X, Awad C, Frey-moreno C, Pumarino-lira S, Descalzi-rojas F, Ruiz TJ, Plass B. Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review. Public Health Rev 2022;43:1604796. [DOI: 10.3389/phrs.2022.1604796] [Reference Citation Analysis]
2 Underberg J, Toth PP, Rodriguez F. LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals. Postgrad Med 2022. [PMID: 36004573 DOI: 10.1080/00325481.2022.2117498] [Reference Citation Analysis]
3 Bremer S, Henjum S, Sæther EM, Hovland R. Drug-related problems and satisfaction among patients receiving pharmacist-led consultations at the initiation of cardiovascular drugs. Res Social Adm Pharm 2022:S1551-7411(22)00183-8. [PMID: 35750567 DOI: 10.1016/j.sapharm.2022.06.005] [Reference Citation Analysis]
4 Khaton Taheri N, Torabizadeh C, Aflaki E, Mohammadi M, Khademian Z. Experiences of the Patients with Behcet's Syndrom from Adherence to Treatment: A Qualitative Content Analysis. Int J Community Based Nurs Midwifery 2021;9:300-12. [PMID: 34604399 DOI: 10.30476/ijcbnm.2021.89726.1640] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Wheat HL, Irani E, Hughes J, Josephson R, Dolansky MA. Insights from Monitoring Aspirin Adherence: A Medication Adherence Cascade Tool. Patient Prefer Adherence 2021;15:1639-46. [PMID: 34345165 DOI: 10.2147/PPA.S315296] [Reference Citation Analysis]
6 Kvarnström K, Westerholm A, Airaksinen M, Liira H. Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research. Pharmaceutics 2021;13:1100. [PMID: 34371791 DOI: 10.3390/pharmaceutics13071100] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
7 Cadel L, Cimino SR, Rolf von den Baumen T, James KA, McCarthy L, Guilcher SJT. Medication Management Frameworks in the Context of Self-Management: A Scoping Review. Patient Prefer Adherence 2021;15:1311-29. [PMID: 34163148 DOI: 10.2147/PPA.S308223] [Reference Citation Analysis]
8 Keng ZY, Saw YM, Thung SC, Chong WW, Albert A, Kariya T, Yamamoto E, Hamajima N. Rate of achievement of therapeutic outcomes and factors associated with control of non-communicable diseases in rural east Malaysia: implications for policy and practice. Sci Rep 2021;11:3812. [PMID: 33589659 DOI: 10.1038/s41598-021-83168-2] [Reference Citation Analysis]
9 Shakarneh JK, Hallak HO, Awadallah HB, Al-Hamed DH, Khdour MR. Necessity and concerns about lipid-lowering medical treatments and risk factors for non-adherence: A cross-sectional study in Palestine. Int J Clin Pract 2020;74:e13511. [PMID: 32279380 DOI: 10.1111/ijcp.13511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Huang HM, Jiang X, Hao ML, Shan MJ, Qiu Y, Hu GF, Wang Q, Yu ZQ, Meng LB, Zou YY. Identification of biomarkers in macrophages of atherosclerosis by microarray analysis. Lipids Health Dis 2019;18:107. [PMID: 31043156 DOI: 10.1186/s12944-019-1056-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]